Ontario’s chief medical officer of health Dr. David Williams announced on Tuesday that the Ontario government is pausing the rollout of the 1st dose of the Oxford-AstraZeneca COVID-19 vaccine in the province out of an abundance of caution because of increased instances of an extremely rare and potentially fatal blood clotting linked to the shot. He added that the decision was also made based on the increased and reliable supply of Pfizer and Moderna as well as the downward trend of COVID-19 cases.
AstraZeneca
Ontario pauses rollout of 1st doses of AstraZeneca COVID-19 vaccine due to safety, supply
More Videos
-
Ontario to unveil COVID-19 booster shots schedule Wednesday
-
WHO clarifies warning on mixing and matching COVID-19 vaccines
-
COVID-19: More than 50% of Ontario adults fully vaccinated
-
NACI guidance leads to confusion among AstraZeneca COVID-19 vaccine recipients
-
COVID-19 vaccine campaign slowdown coming in Canada, experts warn
-
COVID-19: The challenge of booking a 2nd AstraZeneca dose in Ontario
You are viewing an Accelerated Mobile Webpage.
View Original Article